University of California San Francisco

Biography

Dr. Kenzo Hirose is a general surgeon specializing in benign and malignant conditions of the liver, pancreas and bile duct. He has a special interest in minimally invasive surgical techniques and conducts research in patient outcomes after surgery.   

Dr. Kenzo Hirose received his medical degree from Harvard Medical school. He did his residency in general surgery at the University of California, San Francisco and his Hepatopancreatobiliary Fellowship at the Cleveland Clinic. 

 

 

Education

Institution Degree Dept or School End Date
Cleveland Clinic Education Foundation Fellowship 2008
UCSF Medical Center Residency 2006
Harvard School of Medicine 1999

Board Certifications

American Board of Surgery

Clinical Expertise

Bile Duct Injuries
Bile Duct Strictures
Bile Duct Cancer (Cholangiocarcinoma)
Gastrointestinal Carcinoid Tumor
Gastrointestinal Stromal Tumor (GIST)
Choledochal Cysts
Liver Cancer (Hepatocellular Carcinoma)
Minimally Invasive Liver & Pancreas Surgery
Pancreatic Cancer
Pancreatic Cysts
Soft Tissue Sarcomas
Liver Cysts
Liver Metastases
Gallbladder Cancer
Stomach (Gastric) Cancer
Pancreatic Neuroendocrine (Islet Cell) Tumors
Bridging Therapies to Downstage HCC pre-Liver Transplant

Program Affiliations

Hepatobiliary and Pancreas Surgery Program

 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 104
  1. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience.
    Kneuertz PJ, Cunningham SC, Cameron JL, Torrez S, Tapazoglou N, Herman JM, Makary MA, Eckhauser F, Wang J, Hirose K, Edil BH, Choti MA, Schulick RD, Wolfgang CL, Pawlik TM| | PubMed
  2. National trends in surgical procedures for hepatocellular carcinoma: 1998-2008.
    Nathan H, Segev DL, Mayo SC, Choti MA, Cameron AM, Wolfgang CL, Hirose K, Edil BH, Schulick RD, Pawlik TM| | PubMed
  3. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.
    de Jong MC, Hong SM, Augustine MM, Goggins MG, Wolfgang CL, Hirose K, Schulick RD, Choti MA, Anders RA, Pawlik TM| | PubMed
  4. The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma.
    Kamel SI, de Jong MC, Schulick RD, Diaz-Montes TP, Wolfgang CL, Hirose K, Edil BH, Choti MA, Anders RA, Pawlik TM| | PubMed
  5. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.
    Mayo SC, Shore AD, Nathan H, Edil BH, Hirose K, Anders RA, Wolfgang CL, Schulick RD, Choti MA, Pawlik TM| | PubMed
  6. Surgical site infections and cost in obese patients undergoing colorectal surgery.
    Wick EC, Hirose K, Shore AD, Clark JM, Gearhart SL, Efron J, Makary MA| | PubMed
  7. Pay for obesity? Pay-for-performance metrics neglect increased complication rates and cost for obese patients.
    Hirose K, Shore AD, Wick EC, Weiner JP, Makary MA| | PubMed
  8. Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma.
    de Jong MC, Li F, Cameron JL, Wolfgang CL, Edil BH, Herman JM, Choti MA, Eckhauser F, Hirose K, Schulick RD, Pawlik TM| | PubMed
  9. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.
    Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, Herman J, Schulick RD, Choti MA, Pawlik TM| | PubMed
  10. Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis.
    de Jong MC, Tsai S, Cameron JL, Wolfgang CL, Hirose K, van Vledder MG, Eckhauser F, Herman JM, Edil BH, Choti MA, Schulick RD, Pawlik TM| | PubMed